应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
06127 昭衍新药
未开盘 10-02 16:08:34
11.640
+1.850
+18.90%
最高
11.660
最低
9.910
成交量
181.61万
今开
9.910
昨收
9.790
日振幅
17.88%
总市值
87.01亿
流通市值
13.85亿
总股本
7.47亿
成交额
1,972万
换手率
1.53%
流通股本
1.19亿
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
北京优虎网络科技有限公司
免责声明:香港交易所资讯服务有限公司、其控股公司及/或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度,但不能保证其绝对准确和可靠,且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任(不管是否侵权法下的责任或合约责任又或其它责任)
资讯
新帖
简况
昭衍新药盘中异动 早盘股价大涨6.23%报10.400港元
市场透视 · 10-02 09:32
昭衍新药盘中异动 早盘股价大涨6.23%报10.400港元
昭衍新药09月30日主力资金流入482万元 连续7日加仓
市场透视 · 09-30 16:15
昭衍新药09月30日主力资金流入482万元 连续7日加仓
异动解读 | 医药生物概念板块持续走强 昭衍新药盘中涨逾9%
异动解读 · 09-30 13:17
异动解读 | 医药生物概念板块持续走强 昭衍新药盘中涨逾9%
异动快报:昭衍新药(603127)9月30日13点6分触及涨停板
证券之星 · 09-30 13:11
异动快报:昭衍新药(603127)9月30日13点6分触及涨停板
昭衍新药盘中异动 早盘急速上涨5.10%
市场透视 · 09-30 09:30
昭衍新药盘中异动 早盘急速上涨5.10%
昭衍新药:至2024年6月30日尚未行使且未过期的购股权达818,888股
金融界港股 · 09-27
昭衍新药:至2024年6月30日尚未行使且未过期的购股权达818,888股
9月27日昭衍新药涨停分析:健康中国,CAR-T疗法,基因编辑概念热股
证券之星 · 09-27
9月27日昭衍新药涨停分析:健康中国,CAR-T疗法,基因编辑概念热股
A股午评:上交所被买到宕机!半日成交接近万亿!创业板指大涨9.33%
格隆汇 · 09-27
A股午评:上交所被买到宕机!半日成交接近万亿!创业板指大涨9.33%
港股生物技术股持续大涨,药明康德(02359.HK)涨近21%,荣昌生物(09995.HK)涨超20%,宜明昂科(01541.
美港电讯 · 09-27
港股生物技术股持续大涨,药明康德(02359.HK)涨近21%,荣昌生物(09995.HK)涨超20%,宜明昂科(01541.
CRO概念股早盘全线走强 昭衍新药涨超13%药明康德涨超12%
新浪港股 · 09-27
CRO概念股早盘全线走强 昭衍新药涨超13%药明康德涨超12%
A股CRO概念异动拉升,昭衍新药、双成药业双双涨停,药石科技、美迪西、普利制药等均涨近10%,药明康德、康龙化成等跟涨。
美港电讯 · 09-27
A股CRO概念异动拉升,昭衍新药、双成药业双双涨停,药石科技、美迪西、普利制药等均涨近10%,药明康德、康龙化成等跟涨。
异动解读 | 昭衍新药盘中大涨11%遭机构游资资金热捧
异动解读 · 09-27
异动解读 | 昭衍新药盘中大涨11%遭机构游资资金热捧
港股异动 | CRO概念股全线走强 生物安全法案暂遇阻 降息背景下行业有望进一步回暖
智通财经 · 09-27
港股异动 | CRO概念股全线走强 生物安全法案暂遇阻 降息背景下行业有望进一步回暖
异动快报:昭衍新药(603127)9月27日9点58分触及涨停板
证券之星 · 09-27
异动快报:昭衍新药(603127)9月27日9点58分触及涨停板
昭衍新药(06127)上涨10.38%,报8.4元/股
金融界 · 09-27
昭衍新药(06127)上涨10.38%,报8.4元/股
昭衍新药盘中异动 股价大涨5.12%
市场透视 · 09-27
昭衍新药盘中异动 股价大涨5.12%
昭衍新药09月26日主力资金流入14万元 连续5日加仓
市场透视 · 09-26
昭衍新药09月26日主力资金流入14万元 连续5日加仓
港股异动 | CRO概念股持续走高 生物安全法案落地受阻 头部企业投资情绪有望边际回暖
智通财经 · 09-26
港股异动 | CRO概念股持续走高 生物安全法案落地受阻 头部企业投资情绪有望边际回暖
一则利好突袭!CRO概念股集体狂涨,什么情况?
格隆汇 · 09-25
一则利好突袭!CRO概念股集体狂涨,什么情况?
9月24日昭衍新药发生1笔大宗交易 成交金额261.47万元
证券之星 · 09-24
9月24日昭衍新药发生1笔大宗交易 成交金额261.47万元
公司概况
公司名称:
昭衍新药
所属市场:
SEHK
上市日期:
--
主营业务:
北京昭衍新药研究中心股份有限公司是一家主要从事新药药理毒理学研究的中国公司。非临床研究服务包括药物安全性评价、药代动力学研究以及药理和药效学研究。临床试验及相关服务包括临床合同研究组织服务、一期临床研究协作单位 (CRU),以及生物分析服务。实验模型业务主要包括啮齿类及非人灵长类动物。该公司在国内和海外市场开展业务。
发行价格:
--
{"stockData":{"symbol":"06127","market":"HK","secType":"STK","nameCN":"昭衍新药","latestPrice":11.64,"timestamp":1727856514034,"preClose":9.79,"halted":0,"volume":1816149,"delay":0,"floatShares":119000000,"shares":747499020,"eps":0.58524144,"marketStatus":"未开盘","marketStatusCode":0,"change":1.85,"latestTime":"10-02 16:08:34","open":9.91,"high":11.66,"low":9.91,"amount":19722140,"amplitude":0.178754,"askPrice":11.62,"askSize":4600,"bidPrice":11.54,"bidSize":1100,"shortable":0,"etf":0,"ttmEps":0.20374793930451798,"exchange":"SEHK","tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1727919000000},"adr":0,"listingDate":1614268800000,"adjPreClose":9.79,"dividendRate":0.015203,"openAndCloseTimeList":[[1727832600000,1727841600000],[1727845200000,1727856000000]],"volumeRatio":0.475729,"lotSize":100,"spreadScale":0,"tradeCurrency":"HKD","astockBrief":{"symbol":"603127","market":"SH","secType":"STK","nameCN":"昭衍新药","latestPrice":18.05,"timestamp":1727679600000,"preClose":16.41,"halted":0,"volume":51830944,"delay":0,"premium":"-41.60"}},"requestUrl":"/m/hq/s/06127/wiki","defaultTab":"wiki","newsList":[{"id":"2472544715","title":"昭衍新药盘中异动 早盘股价大涨6.23%报10.400港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2472544715","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2472544715?lang=zh_cn&edition=full","pubTime":"2024-10-02 09:32","pubTimestamp":1727832748,"startTime":"0","endTime":"0","summary":"2024年10月02日早盘09时32分,昭衍新药股票出现异动,股价急速上涨6.23%。截至发稿,该股报10.400港元/股,成交量5600股,换手率0.00%,振幅5.01%。资金方面,该股资金流入2.0159万港元,流出3.4024万港元。昭衍新药股票所在的生物技术行业中,整体跌幅为1.15%。其相关个股中,贝康医疗-B、维亚生物、药明巨诺-B涨幅较大,振幅较大的相关个股有贝康医疗-B、泰格医药、基石药业-B,振幅分别为8.41%、7.73%、7.18%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202410020932299719dcee&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202410020932299719dcee&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1576","06127","BK1141"],"gpt_icon":0},{"id":"2471682038","title":"昭衍新药09月30日主力资金流入482万元 连续7日加仓","url":"https://stock-news.laohu8.com/highlight/detail?id=2471682038","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2471682038?lang=zh_cn&edition=full","pubTime":"2024-09-30 16:15","pubTimestamp":1727684130,"startTime":"0","endTime":"0","summary":"09月30日, 昭衍新药股价涨11.00%,报收9.79元,成交金额7758万元,换手率6.77%,振幅12.24%,量比3.31。昭衍新药今日主力资金净流入482万元,连续7日净流入,上一交易日主力净流入918万元,今日环比减少47.49%。该股近5个交易日上涨38.67%,主力资金累计净流入1614万元;近20日主力资金累计净流入1444万元,其中净流入天数为7日。该股主力净额占比0.41%,港股市场排名37/2636。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202409301616239f20d32e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202409301616239f20d32e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1576","06127","BK1141"],"gpt_icon":0},{"id":"1147546791","title":"异动解读 | 医药生物概念板块持续走强 昭衍新药盘中涨逾9%","url":"https://stock-news.laohu8.com/highlight/detail?id=1147546791","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1147546791?lang=zh_cn&edition=full","pubTime":"2024-09-30 13:17","pubTimestamp":1727673426,"startTime":"0","endTime":"0","summary":"今日医药生物板块持续走强,昭衍新药股价随之大涨。截至发稿时,该股盘中大涨9.75%,股价上探18.05元,盘中更是一度触及涨停板。从盘面数据来看,昭衍新药所属的医疗服务行业和CAR-T疗法、干细胞、健康中国等相关概念板块今日集体走强,成为推动该股大涨的主要动力。业内人士分析称,近期医药生物板块持续受到资金追捧,投资者对医疗服务行业的未来发展预期向好,有利于拉动相关个股上涨。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"异动解读 | 医药生物概念板块持续走强 昭衍新药盘中涨逾9%","news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["06127"],"gpt_icon":0},{"id":"2471844652","title":"异动快报:昭衍新药(603127)9月30日13点6分触及涨停板","url":"https://stock-news.laohu8.com/highlight/detail?id=2471844652","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2471844652?lang=zh_cn&edition=full","pubTime":"2024-09-30 13:11","pubTimestamp":1727673074,"startTime":"0","endTime":"0","summary":"证券之星9月30日盘中消息,13点6分昭衍新药触及涨停板。目前价格18.05,上涨9.99%。9月27日的资金流向数据方面,主力资金净流入5831.61万元,占总成交额21.89%,游资资金净流出2626.67万元,占总成交额9.86%,散户资金净流出3204.94万元,占总成交额12.03%。近5日资金流向一览见下表:昭衍新药主要指标及行业内排名如下:以上内容为证券之星据公开信息整理,由智能算法生成,不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024093000018086.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK1576","06127","603127","BK1141","BK0216"],"gpt_icon":0},{"id":"2471813004","title":"昭衍新药盘中异动 早盘急速上涨5.10%","url":"https://stock-news.laohu8.com/highlight/detail?id=2471813004","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2471813004?lang=zh_cn&edition=full","pubTime":"2024-09-30 09:30","pubTimestamp":1727659808,"startTime":"0","endTime":"0","summary":"2024年09月30日早盘09时30分,昭衍新药股票出现波动,股价大幅拉升5.10%。截至发稿,该股报9.270港元/股,成交量3.85万股,换手率0.03%,振幅0.79%。昭衍新药股票所在的生物技术行业中,整体涨幅为1.43%。其相关个股中,北海康成-B、康宁杰瑞制药-B、药明生物涨幅较大,振幅较大的相关个股有康宁杰瑞制药-B、方达控股、巨子生物,振幅分别为16.01%、6.67%、3.11%。消息层面,截至09时30分,昭衍新药股票正面舆情新闻比例33.33%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024093009300998e398ae&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024093009300998e398ae&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1576","06127","BK1141"],"gpt_icon":0},{"id":"2470770899","title":"昭衍新药:至2024年6月30日尚未行使且未过期的购股权达818,888股","url":"https://stock-news.laohu8.com/highlight/detail?id=2470770899","media":"金融界港股","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2470770899?lang=zh_cn&edition=full","pubTime":"2024-09-27 17:46","pubTimestamp":1727430360,"startTime":"0","endTime":"0","summary":"金融界9月27日消息,根据昭衍新药2024年中期报告,至2024年6月30日,首次公开发售前购股权及受限制股份奖励计划项下的尚未行使且尚未过期的购股权的A股股份总数为818,888股。其中,董事左从林、高大鹏、孙云霞以及姚大林尚未行使的购股权分别为37,632、11,760、11,760以及11,760股。首席财务官于爱水尚未行使的购股权为5,880股,其他员工的尚未行使购股权为740,096股。\n\n\r\n 责任编辑:钟离","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://hk.jrj.com.cn/2024/09/27174643581402.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["BK1141","BK1576","BK0216","603127","06127"],"gpt_icon":0},{"id":"2470781857","title":"9月27日昭衍新药涨停分析:健康中国,CAR-T疗法,基因编辑概念热股","url":"https://stock-news.laohu8.com/highlight/detail?id=2470781857","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2470781857?lang=zh_cn&edition=full","pubTime":"2024-09-27 15:49","pubTimestamp":1727423375,"startTime":"0","endTime":"0","summary":"证券之星消息,昭衍新药9月27日涨停收盘,收盘价16.41元。该股于9点58分涨停,未打开涨停,截止收盘封单资金为5075.92万元,占其流通市值0.49%。9月27日的资金流向数据方面,主力资金净流入5831.61万元,占总成交额21.89%,游资资金净流出2626.67万元,占总成交额9.86%,散户资金净流出3204.94万元,占总成交额12.03%。近5日资金流向一览见下表:该股为健康中国,CAR-T疗法,基因编辑概念热股,当日健康中国概念上涨6.64%,CAR-T疗法概念上涨5.82%,基因编辑概念上涨5.63%。以上内容为证券之星据公开信息整理,由智能算法生成,不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024092700020997.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["06127","BK1576","BK0216","603127","BK1141"],"gpt_icon":0},{"id":"2470874143","title":"A股午评:上交所被买到宕机!半日成交接近万亿!创业板指大涨9.33%","url":"https://stock-news.laohu8.com/highlight/detail?id=2470874143","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2470874143?lang=zh_cn&edition=full","pubTime":"2024-09-27 11:56","pubTimestamp":1727409390,"startTime":"0","endTime":"0","summary":"A股主要指数早盘集体放量大涨,上交所一度被买到宕机!截至午间收盘,沪指涨2.14%报3065.29点,深成指涨6.37%,创业板指涨9.33%,半日成交接近万亿!","market":"sg","thumbnail":"https://img3.gelonghui.com/20b77-f0f73b20-83f0-41f3-b6ef-3c433eea8e16.png","type":0,"news_type":0,"thumbnails":["https://img3.gelonghui.com/20b77-f0f73b20-83f0-41f3-b6ef-3c433eea8e16.png"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.gelonghui.com/p/1099573","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"gelonghui_highlight","symbols":["LU0348805143.USD","LU0873338254.USD","LU0327786744.USD","LU0211977185.USD","LU0605514214.HKD","BK0015","LU0405327494.USD","LU0501845795.SGD","03189","BK0183","LU0577902611.USD","LU0516422366.SGD","LU0572944931.SGD","LU0594300419.USD","LU0348825331.USD","LU0251143458.SGD","BK0182","LU0456827905.SGD","BK0196","LU0084288322.USD","LU0417516902.SGD","BK0188","LU0370786039.SGD","601162","BK0215","LU0405327148.USD","LU0880133367.SGD","LU0823426480.USD","06127","600519","LU0067412154.USD","603799","LU0048580855.USD","LU0348816934.USD","LU0588546209.SGD","02359","BK1576","LU0577902454.USD","LU0359202008.SGD","LU0823426308.USD","83189","LU0577902371.SGD","LU0651946864.USD","LU0878005551.USD","09988","LU0051755006.USD","LU0052750758.USD","LU0516423174.USD","BK0077","LU0326950275.SGD","LU0039217434.USD","BK0175"],"gpt_icon":1},{"id":"2470973749","title":"港股生物技术股持续大涨,药明康德(02359.HK)涨近21%,荣昌生物(09995.HK)涨超20%,宜明昂科(01541.","url":"https://stock-news.laohu8.com/highlight/detail?id=2470973749","media":"美港电讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2470973749?lang=zh_cn&edition=full","pubTime":"2024-09-27 11:45","pubTimestamp":1727408741,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.ushknews.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_meigang","symbols":["603259","BK1141","LU0819121731.USD","LU1242518857.USD","LU2125910500.SGD","02359","07226","HK0000306701.USD","01541","LU0516423091.SGD","LU0516423174.USD","06127","LU2045819591.USD","09995","LU1880383366.USD","LU0516422366.SGD","LU2242644610.SGD","HK0000306685.HKD","LU1794554557.SGD","LU0708995583.HKD","LU0456827905.SGD","LU0516422952.EUR","LU2488822045.USD","LU0359202008.SGD","LU1064130708.USD","HSCEI","LU0320764599.SGD","LU0456842615.SGD","688331","LU0181495838.USD","LU2148510915.USD","LU0456846285.SGD","LU0588546209.SGD","BK1574","LU1242518931.SGD","BK1576","LU0140636845.USD","LU0326950275.SGD","YANG","LU0327786744.USD","01548","BK1583","BK1610","LU0307460666.USD","LU1046422090.SGD","LU1969619763.USD","LU0039217434.USD","603127","02269","HSTECH"],"gpt_icon":0},{"id":"2470710214","title":"CRO概念股早盘全线走强 昭衍新药涨超13%药明康德涨超12%","url":"https://stock-news.laohu8.com/highlight/detail?id=2470710214","media":"新浪港股","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2470710214?lang=zh_cn&edition=full","pubTime":"2024-09-27 10:27","pubTimestamp":1727404020,"startTime":"0","endTime":"0","summary":"热点栏目\n\n自选股\n数据中心\n行情中心\n资金流向\n模拟交易\n\n客户端\n\n\n CRO概念股早盘全线走强,昭衍新药(06127)上涨13.54%,报8.64港元;药明康德(02359)上涨12.41%,报46.65港元;药明生物(02269)上涨9.38%,报15.15港元;康龙化成(03759)上涨7.45%,报12.12港元。\n\n\n\n海量资讯、精准解读,尽在新浪财经APP\n\n责任编辑:卢昱君","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/stock/hkstock/marketalerts/2024-09-27/doc-incqqcqh1802566.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/hkstock/marketalerts/2024-09-27/doc-incqqcqh1802566.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["603259","LU1997245094.SGD","LU2242644610.SGD","LU0052750758.USD","LU0320764599.SGD","BK1576","LU0456842615.SGD","BK0216","LU2125910500.SGD","06127","LU2045819591.USD","LU0708995583.HKD","LU2488822045.USD","603127","02359","BK1141","LU1997245177.USD","02269","BK1583","LU1046422090.SGD"],"gpt_icon":0},{"id":"2470717608","title":"A股CRO概念异动拉升,昭衍新药、双成药业双双涨停,药石科技、美迪西、普利制药等均涨近10%,药明康德、康龙化成等跟涨。","url":"https://stock-news.laohu8.com/highlight/detail?id=2470717608","media":"美港电讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2470717608?lang=zh_cn&edition=full","pubTime":"2024-09-27 10:15","pubTimestamp":1727403344,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.ushknews.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_meigang","symbols":["LU2242644610.SGD","LU0052750758.USD","06127","399300","LU2125910500.SGD","LU0320764599.SGD","LU1046422090.SGD","LU1997245094.SGD","02359","002693","688202","300630","LU0708995583.HKD","BK1141","BK1576","LU2045819591.USD","LU2488822045.USD","BK0239","03759","LU0456842615.SGD","300725","LU1997245177.USD","159982","603259","BK1583","BK0216","300759","603127","BK0229"],"gpt_icon":0},{"id":"1189482624","title":"异动解读 | 昭衍新药盘中大涨11%遭机构游资资金热捧","url":"https://stock-news.laohu8.com/highlight/detail?id=1189482624","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1189482624?lang=zh_cn&edition=full","pubTime":"2024-09-27 10:07","pubTimestamp":1727402830,"startTime":"0","endTime":"0","summary":"今日上午,昭衍新药(603127)股价出现异动,盘中一度大涨11.04%,引发了市场广泛关注。分析公开资料,此次股价大涨或与机构、游资入场资金扫货有关。\n\n根据证券之星的统计数据,昭衍新药昨日主力资金净流入2534.99万元,占成交额7.41%。而游资资金则净流出1513.64万元。这表明不少机构资金大举买入该股,而游资则扫出获利。\n\n昭衍新药作为一家生物科技公司,近期业绩和基本面没有重大变化。因此短期内股价大涨的主因很可能是机构以及游资资金的密集入场,推动了股价快速上行。不过这种驱动下的股价上涨是否持久,还有待进一步观察。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"异动解读 | 昭衍新药盘中大涨11%遭机构游资资金热捧","news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["06127"],"gpt_icon":0},{"id":"2470510717","title":"港股异动 | CRO概念股全线走强 生物安全法案暂遇阻 降息背景下行业有望进一步回暖","url":"https://stock-news.laohu8.com/highlight/detail?id=2470510717","media":"智通财经","labels":["Policy And Regulatory","movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2470510717?lang=zh_cn&edition=full","pubTime":"2024-09-27 10:03","pubTimestamp":1727402620,"startTime":"0","endTime":"0","summary":"考虑到美联储正式启动降息、行业订单边际改善,预计头部CXO的投资情绪将边际回暖,但进一步估值修复或许需要更多业绩复苏的能见度。民生证券近日指出,生物安全法案未纳入参议院2025NDAA,夹带立法途径失效,单独立法方面H.R.8333将进入参议院程序,2024年参议院工作日还有6周,关注参议院排期和投票进程;美联储降息50bp,biotech融资端有望延续上半年改善趋势,以海外客户为主要订单和收入贡献的CXO龙头有望进一步回暖。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1187941.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"Policy And Regulatory,movement","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1141","LU1046422090.SGD","LU0456846285.SGD","LU0052750758.USD","LU0307460666.USD","LU0043850808.USD","LU0572944931.SGD","LU0181495838.USD","02359","LU0326950275.SGD","BK1576","LU0051755006.USD","LU0348735423.USD","LU0359201612.USD","LU0979878070.USD","LU0140636845.USD","03759","LU1794554557.SGD","LU2125910500.SGD","LU0039217434.USD","LU0856984785.SGD","BK1589","LU0819121731.USD","LU0516423091.SGD","LU0823426480.USD","SG9999002463.SGD","LU0359202008.SGD","LU0516423174.USD","LU0823426308.USD","LU0456827905.SGD","LU1242518931.SGD","BK1610","LU2242644610.SGD","LU0417516738.SGD","LU0320764599.SGD","LU1242518857.USD","LU0588546209.SGD","BK1583","06127","BK1521","LU0417516902.SGD","LU0348825331.USD","SG9999002562.SGD","LU0516422440.USD","LU0327786744.USD","02269","LU2045819591.USD","LU1720050803.USD","LU0516422952.EUR","IE00B0JY6N72.USD"],"gpt_icon":1},{"id":"2470171269","title":"异动快报:昭衍新药(603127)9月27日9点58分触及涨停板","url":"https://stock-news.laohu8.com/highlight/detail?id=2470171269","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2470171269?lang=zh_cn&edition=full","pubTime":"2024-09-27 10:01","pubTimestamp":1727402511,"startTime":"0","endTime":"0","summary":"证券之星9月27日盘中消息,9点58分昭衍新药触及涨停板。目前价格16.41,上涨9.99%。领涨股为迪安诊断。9月26日的资金流向数据方面,主力资金净流入2534.99万元,占总成交额7.41%,游资资金净流出1513.64万元,占总成交额4.43%,散户资金净流出1021.34万元,占总成交额2.99%。近5日资金流向一览见下表:昭衍新药主要指标及行业内排名如下:以上内容为证券之星据公开信息整理,由智能算法生成,不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024092700008587.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK1141","BK1576","06127","BK0216","603127"],"gpt_icon":0},{"id":"2470203712","title":"昭衍新药(06127)上涨10.38%,报8.4元/股","url":"https://stock-news.laohu8.com/highlight/detail?id=2470203712","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2470203712?lang=zh_cn&edition=full","pubTime":"2024-09-27 10:00","pubTimestamp":1727402453,"startTime":"0","endTime":"0","summary":"9月27日,昭衍新药(06127)盘中上涨10.38%,截至10:00,报8.4元/股,成交926.56万元。北京昭衍新药研究中心股份有限公司是一家专业的药物研发服务外包企业,主要提供非临床药理毒理学研究及评价、临床试验及药物警戒等一站式服务,以及兽药、农药及医疗器械评价等服务。公司在北京和苏州设有73200平方米的动物实验设施,是中国从事非临床安全性评价服务最大的机构之一,能够提供药物、医疗器械、兽药、农药及其他新化学品的个性化方案设计、药物筛选、药效学研究、药代动力学研究、安全性评价等服务。截至2024年中报,昭衍新药营业总收入8.49亿元、净利润-1.7亿元。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://hk.jrj.com.cn/2024/09/27100043561297.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["BK1141","603127","BK0216","BK1576","06127"],"gpt_icon":0},{"id":"2470712960","title":"昭衍新药盘中异动 股价大涨5.12%","url":"https://stock-news.laohu8.com/highlight/detail?id=2470712960","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2470712960?lang=zh_cn&edition=full","pubTime":"2024-09-27 09:33","pubTimestamp":1727400791,"startTime":"0","endTime":"0","summary":"2024年09月27日早盘09时33分,昭衍新药股票出现异动,股价大幅上涨5.12%。截至发稿,该股报8.000港元/股,成交量24.3万股,换手率0.20%,振幅3.15%。资金方面,该股资金流入100.156万港元,流出73.8179万港元。昭衍新药股票所在的生物技术行业中,整体跌幅为0.08%。其相关个股中,来凯医药-B、再鼎医药、贝康医疗-B涨幅较大,振幅较大的相关个股有来凯医药-B、诺诚健华、荣昌生物,振幅分别为6.78%、6.26%、5.59%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240927093311ab664e56&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240927093311ab664e56&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1141","BK1576","06127"],"gpt_icon":0},{"id":"2470118201","title":"昭衍新药09月26日主力资金流入14万元 连续5日加仓","url":"https://stock-news.laohu8.com/highlight/detail?id=2470118201","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2470118201?lang=zh_cn&edition=full","pubTime":"2024-09-26 16:15","pubTimestamp":1727338507,"startTime":"0","endTime":"0","summary":"09月26日, 昭衍新药股价涨4.39%,报收7.61元,成交金额949万元,换手率1.07%,振幅6.72%,量比0.92。昭衍新药今日主力资金净流入14万元,连续5日净流入,上一交易日主力净流入45万元,今日环比减少68.89%。该股近5个交易日上涨11.91%,主力资金累计净流入306万元,其中1个交易日为股价下跌时净流入;近20日主力资金累计净流入5万元,其中净流入天数为6日。该股主力净额占比0.02%,港股市场排名530/2637。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240926161521957ed2df&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240926161521957ed2df&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1576","06127","BK1141"],"gpt_icon":0},{"id":"2470208672","title":"港股异动 | CRO概念股持续走高 生物安全法案落地受阻 头部企业投资情绪有望边际回暖","url":"https://stock-news.laohu8.com/highlight/detail?id=2470208672","media":"智通财经","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2470208672?lang=zh_cn&edition=full","pubTime":"2024-09-26 15:24","pubTimestamp":1727335458,"startTime":"0","endTime":"0","summary":"消息面上,据美国国会官网,美《生物安全法》立法一事又有进展。在最新的修正案中,药明生物已经被除名。交银国际指出,考虑到美联储正式启动降息、行业订单边际改善,预计头部CXO的投资情绪将边际回暖,但进一步估值修复或许需要更多业绩复苏的能见度。国信证券表示,随着海外投融资的逐季度恢复,美联储开启降息周期,部分CXO板块公司的收入及利润有望呈现逐季度环比改善趋势,海外业务占比大的公司有望改善更加明显。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1187461.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["LU0181495838.USD","LU0516422366.SGD","LU0823426308.USD","IE00B0JY6N72.USD","LU1242518931.SGD","LU1688375341.USD","LU0456846285.SGD","LU1720050803.USD","LU0856984785.SGD","LU0516422440.USD","BK1521","03347","LU0348825331.USD","BK1583","LU0588546209.SGD","LU0043850808.USD","LU0823426480.USD","LU1242518857.USD","LU2039709279.SGD","LU1046422090.SGD","LU0140636845.USD","LU0320764599.SGD","LU0456827905.SGD","BK1576","SG9999002562.SGD","LU0516423091.SGD","LU0039217434.USD","02359","LU0516423174.USD","03759","LU0348735423.USD","LU0359202008.SGD","BK1589","LU0417516738.SGD","LU2045819591.USD","06127","LU0572944931.SGD","LU2125910500.SGD","BK1141","02269","LU1880383366.USD","LU0417516902.SGD","LU0708995583.HKD","LU2242644610.SGD","LU0359201612.USD","LU1794554557.SGD","BK1610","LU0819121731.USD","LU0327786744.USD","LU0307460666.USD"],"gpt_icon":1},{"id":"2470282187","title":"一则利好突袭!CRO概念股集体狂涨,什么情况?","url":"https://stock-news.laohu8.com/highlight/detail?id=2470282187","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2470282187?lang=zh_cn&edition=full","pubTime":"2024-09-25 15:58","pubTimestamp":1727251108,"startTime":"0","endTime":"0","summary":"机构:关注板块底部机会","market":"sg","thumbnail":"https://img3.gelonghui.com/9f4a7-7b1ceab3-507b-4d8a-83ee-878d26b649b7.jpg?guru_height=853&guru_width=1280","type":0,"news_type":0,"thumbnails":["https://img3.gelonghui.com/9f4a7-7b1ceab3-507b-4d8a-83ee-878d26b649b7.jpg?guru_height=853&guru_width=1280"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.gelonghui.com/p/1089046","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"gelonghui_highlight","symbols":["03347","LU0456842615.SGD","06127","BK0216","300630","LU1997245094.SGD","603259","02269","BK0239","300149","BK1191","06821","BK0077","PRTG","LU1997245177.USD","LU2488822045.USD","002693"],"gpt_icon":1},{"id":"2469450145","title":"9月24日昭衍新药发生1笔大宗交易 成交金额261.47万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2469450145","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2469450145?lang=zh_cn&edition=full","pubTime":"2024-09-24 17:29","pubTimestamp":1727170145,"startTime":"0","endTime":"0","summary":"证券之星消息,9月24日昭衍新药发生大宗交易,交易数据如下:大宗交易成交价格14.08元,成交18.57万股,成交金额261.47万元,买方营业部为中信证券股份有限公司上海分公司,卖方营业部为中国中金财富证券有限公司北京北三环东路证券营业部。近三个月该股共发生2笔大宗交易,合计成交4301.0手。以上内容为证券之星据公开信息整理,由智能算法生成,不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024092400027019.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["06127","603127","BK1141","BK1576","BK0216"],"gpt_icon":0}],"profile":{"stockEarnings":[{"period":"1week","weight":0.5967},{"period":"1month","weight":0.769},{"period":"3month","weight":0.5709},{"period":"6month","weight":0.4463},{"period":"1year","weight":-0.0557},{"period":"ytd","weight":-0.0733}],"compareEarnings":[{"period":"1week","weight":0.1733},{"period":"1month","weight":0.2686},{"period":"3month","weight":0.2449},{"period":"6month","weight":0.342},{"period":"1year","weight":0.295},{"period":"ytd","weight":0.3165}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"北京昭衍新药研究中心股份有限公司是一家主要从事新药药理毒理学研究的中国公司。非临床研究服务包括药物安全性评价、药代动力学研究以及药理和药效学研究。临床试验及相关服务包括临床合同研究组织服务、一期临床研究协作单位 (CRU),以及生物分析服务。实验模型业务主要包括啮齿类及非人灵长类动物。该公司在国内和海外市场开展业务。","yearOnYearQuotes":[{"month":1,"riseRate":0.333333,"avgChangeRate":-0.116169},{"month":2,"riseRate":0.666667,"avgChangeRate":-0.004245},{"month":3,"riseRate":0.25,"avgChangeRate":-0.021642},{"month":4,"riseRate":0.25,"avgChangeRate":-0.064961},{"month":5,"riseRate":0.75,"avgChangeRate":0.028518},{"month":6,"riseRate":0.5,"avgChangeRate":0.026858},{"month":7,"riseRate":0.75,"avgChangeRate":0.036307},{"month":8,"riseRate":0,"avgChangeRate":-0.164063},{"month":9,"riseRate":0.5,"avgChangeRate":0.001124},{"month":10,"riseRate":0.5,"avgChangeRate":0.010412},{"month":11,"riseRate":0.333333,"avgChangeRate":0.09357},{"month":12,"riseRate":0.333333,"avgChangeRate":-0.082025}],"exchange":"SEHK","name":"昭衍新药","nameEN":"JOINN"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.28.3","shortVersion":"4.28.3","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"昭衍新药(06127)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供昭衍新药(06127)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"昭衍新药,06127,昭衍新药股票,昭衍新药股票老虎,昭衍新药股票老虎国际,昭衍新药行情,昭衍新药股票行情,昭衍新药股价,昭衍新药股市,昭衍新药股票价格,昭衍新药股票交易,昭衍新药股票购买,昭衍新药股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"昭衍新药(06127)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供昭衍新药(06127)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}